Literature DB >> 18378573

Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease.

M Elizabeth Hartnett1, David Martiniuk, Grace Byfield, Pete Geisen, Gefei Zeng, Victoria L Bautch.   

Abstract

PURPOSE: To study the effects of vascular endothelial growth factor (VEGF) on endothelial nitric oxide synthetase (eNOS) and retinal vascular tortuosity and cleavage planes in a rat model of retinopathy of prematurity (ROP).
METHODS: Within 4 hours of birth, pups and mothers were cycled between 50% and 10% oxygen daily. At postnatal day (p)12, pups received either intravitreous anti-rat neutralizing antibody to VEGF or control nonimmune rat IgG in one eye and returned to oxygen cycling until p14 when they were placed in room air (RA) for 4 days (50/10 oxygen-induced retinopathy [50/10 OIR]). Tortuosity indices and endothelial cleavage plane angles relative to the long axes of the major retinal vessels during anaphase were calculated from phosphohistone- and Alexa-isolectin-stained retinal flatmounts. Some retinas were processed for eNOS protein or phosphorylated/total eNOS.
RESULTS: Retinas from 50/10 OIR had increased tortuosity over time with peaks at p12 and p14 (P < 0.001 vs. RA) before the development of intravitreous neovascularization, which peaked at p18. Compared with RA, eNOS/actin in 50/10 OIR retinas was increased at p12 (P = 0.0003) and p14 (P = 0.047). Inhibition of VEGF with a neutralizing antibody decreased tortuosity and caused endothelial mitosis cleavage planes to orient in favor of vessel elongation but did not affect eNOS protein or activation.
CONCLUSIONS: In the 50/10 OIR model, a model with relevance to ROP, arteriolar tortuosity, and venous dilation are increased through VEGF, which influences the orientation of endothelial cell cleavage in major arterioles and veins, independent of eNOS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378573      PMCID: PMC2459334          DOI: 10.1167/iovs.08-1780

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  35 in total

1.  Assembly and reorientation of stress fibers drives morphological changes to endothelial cells exposed to shear stress.

Authors:  Sabrena Noria; Feng Xu; Shannon McCue; Mara Jones; Avrum I Gotlieb; B Lowell Langille
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

2.  Transcutaneous oxygen levels in retinopathy of prematurity.

Authors:  S Cunningham; B W Fleck; R A Elton; N McIntosh
Journal:  Lancet       Date:  1995-12-02       Impact factor: 79.321

3.  Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease.

Authors:  Susumu Ishida; Kenji Yamashiro; Tomohiko Usui; Yuichi Kaji; Yuichiro Ogura; Tetsuo Hida; Yoshihito Honda; Yoshihisa Oguchi; Anthony P Adamis
Journal:  Nat Med       Date:  2003-05-05       Impact factor: 53.440

4.  Retrolental Fibroplasia. II. Pathologic correlation.

Authors:  B J Kushner; D Essner; I J Cohen; J T Flynn
Journal:  Arch Ophthalmol       Date:  1977-01

5.  Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat.

Authors:  J S Penn; M M Henry; B L Tolman
Journal:  Pediatr Res       Date:  1994-12       Impact factor: 3.756

6.  Diameter and length changes in cerebral collaterals after middle cerebral artery occlusion in the young rat.

Authors:  P Coyle
Journal:  Anat Rec       Date:  1984-10

7.  The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats.

Authors:  J S Penn; M M Henry; P T Wall; B L Tolman
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-09       Impact factor: 4.799

8.  Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.

Authors:  S Banai; M T Jaklitsch; M Shou; D F Lazarous; M Scheinowitz; S Biro; S E Epstein; E F Unger
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

9.  The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis.

Authors:  T Chan-Ling; B Gock; J Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-06       Impact factor: 4.799

10.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia.

Authors:  Holger Gerhardt; Matthew Golding; Marcus Fruttiger; Christiana Ruhrberg; Andrea Lundkvist; Alexandra Abramsson; Michael Jeltsch; Christopher Mitchell; Kari Alitalo; David Shima; Christer Betsholtz
Journal:  J Cell Biol       Date:  2003-06-16       Impact factor: 10.539

View more
  43 in total

1.  Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity.

Authors:  Steven J Budd; M Elizabeth Hartnett
Journal:  Arch Ophthalmol       Date:  2010-05

2.  Intravitreal bevacizumab treatment reduces ocular blood flow in retinopathy of prematurity: a four-case report.

Authors:  Tadashi Matsumoto; Takashi Itokawa; Tomoaki Shiba; Masahiko Tomita; Kotaro Hine; Norio Mizukaki; Hitoshi Yoda; Yuichi Hori
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-06       Impact factor: 3.117

3.  Retinal vascular geometry and 6 year incidence and progression of diabetic retinopathy.

Authors:  Carol Yim-Lui Cheung; Charumathi Sabanayagam; Antony Kwan-Pui Law; Neelam Kumari; Daniel Shu-Wei Ting; Gavin Tan; Paul Mitchell; Ching Yu Cheng; Tien Yin Wong
Journal:  Diabetologia       Date:  2017-06-16       Impact factor: 10.122

4.  Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels.

Authors:  Joo Yong Lee; Ju Byung Chae; Sung Jae Yang; Young Hee Yoon; June-Gone Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09       Impact factor: 3.117

5.  A murine model for retinopathy of prematurity identifies endothelial cell proliferation as a potential mechanism for plus disease.

Authors:  Victor H Guaiquil; Nina J Hewing; Michael F Chiang; Mark I Rosenblatt; R V Paul Chan; Carl P Blobel
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-07       Impact factor: 4.799

6.  Plus Disease: Why is it Important in Retinopathy of Prematurity?

Authors:  Carlos E Solarte; Abdulaziz H Awad; Clare M Wilson; Anna Ells
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

7.  Next-generation sequencing analysis of gene regulation in the rat model of retinopathy of prematurity.

Authors:  Rachel M Griffith; Hu Li; Nan Zhang; Tara L Favazza; Anne B Fulton; Ronald M Hansen; James D Akula
Journal:  Doc Ophthalmol       Date:  2013-06-18       Impact factor: 2.379

8.  Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity.

Authors:  Haibo Wang; Zhihong Yang; Yanchao Jiang; John Flannery; Scott Hammond; Tal Kafri; Sai Karthik Vemuri; Bryan Jones; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-04       Impact factor: 4.799

9.  Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity.

Authors:  Yanchao Jiang; Haibo Wang; David Culp; Zhihong Yang; Lori Fotheringham; John Flannery; Scott Hammond; Tal Kafri; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-10       Impact factor: 4.799

Review 10.  The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model.

Authors:  M Elizabeth Hartnett
Journal:  Doc Ophthalmol       Date:  2009-07-29       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.